{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:20:48Z","timestamp":1792120848386,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.omto.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T02:41:12Z","timestamp":1669948872000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A library of cancer testis specific T\u00a0cell receptors for T\u00a0cell receptor gene therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Marije A.J.","family":"de Rooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis F.G.","family":"Remst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"van der Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate S.","family":"Hagedoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel G.D.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda H.","family":"Meeuwsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassilo L.A.","family":"Wachsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud H.","family":"de Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"van Veelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els M.E.","family":"Verdegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H. Frederik","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-9133","authenticated-orcid":false,"given":"Mirjam H.M.","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2022.11.007_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omto.2022.11.007_bib2","first-page":"105","article-title":"Electron microscopic observations on the structural components of the blood-testis barrier","volume":"10","author":"Fawcett","year":"1970","journal-title":"J.\u00a0Reprod. Fertil. Suppl."},{"key":"10.1016\/j.omto.2022.11.007_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1439-0272.1993.tb02686.x","article-title":"Lack of HLA-molecules on human spermatozoa and in seminal plasma","volume":"25","author":"Schaller","year":"1993","journal-title":"Andrologia"},{"key":"10.1016\/j.omto.2022.11.007_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1439-0272.1989.tb02401.x","article-title":"Evaluation of HLA expression on gametogenic cells isolated from human testis","volume":"21","author":"Kowalik","year":"1989","journal-title":"Andrologia"},{"key":"10.1016\/j.omto.2022.11.007_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20031677","article-title":"Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters","volume":"199","author":"Gotter","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2022.11.007_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1084\/jem.185.5.833","article-title":"Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes","volume":"185","author":"Theobald","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2022.11.007_bib7","doi-asserted-by":"crossref","first-page":"e000203","DOI":"10.1136\/esmoopen-2017-000203","article-title":"Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I\/II study with a first assessment of a predictive gene signature","volume":"2","author":"Grob","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.omto.2022.11.007_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2022.11.007_bib9","doi-asserted-by":"crossref","first-page":"13114","DOI":"10.1073\/pnas.93.23.13114","article-title":"Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy","volume":"93","author":"Sadovnikova","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2022.11.007_bib10","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-11-1066","article-title":"PRAME-specific Allo-HLA-restricted T\u00a0cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer","volume":"17","author":"Amir","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omto.2022.11.007_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamaophthalmol.2017.0729","article-title":"PRAME as a potential target for immunotherapy in metastatic uveal melanoma","volume":"135","author":"Gezgin","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.omto.2022.11.007_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood-2016-09-737536","article-title":"TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1","volume":"129","author":"Jahn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omto.2022.11.007_bib13","doi-asserted-by":"crossref","first-page":"e1507600","DOI":"10.1080\/2162402X.2018.1507600","article-title":"PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy","volume":"7","author":"Luk","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.omto.2022.11.007_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T\u00a0cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omto.2022.11.007_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omto.2022.11.007_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ymthe.2018.02.017","article-title":"Preclinical strategies to identify off-target toxicity of high-affinity TCRs","volume":"26","author":"Bijen","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.11.007_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","article-title":"MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases","volume":"39","author":"Doyle","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omto.2022.11.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.08.002","article-title":"The MAGE protein family and cancer","volume":"37","author":"Weon","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.omto.2022.11.007_bib19","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2012.43.7111","article-title":"Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European organisation for research and treatment of cancer melanoma group in metastatic melanoma","volume":"31","author":"Kruit","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2022.11.007_bib20","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/acs.jmedchem.9b01226","article-title":"The immunoproteasome: an emerging target in cancer and autoimmune and neurological disorders","volume":"63","author":"Zerfas","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.11.007_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.17.1.739","article-title":"Degradation of cell proteins and the generation of MHC class I-presented peptides","volume":"17","author":"Rock","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omto.2022.11.007_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0092-8674(94)90462-6","article-title":"Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules","volume":"78","author":"Rock","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.omto.2022.11.007_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.jbchem.a124327","article-title":"Interferon-gamma induces different subunit organizations and functional diversity of proteasomes","volume":"115","author":"Aki","year":"1994","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.omto.2022.11.007_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/365262a0","article-title":"MHC-linked LMP gene products specifically alter peptidase activities of the proteasome","volume":"365","author":"Driscoll","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.11.007_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/365264a0","article-title":"Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes","volume":"365","author":"Gaczynska","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.omto.2022.11.007_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymthe.2021.08.010","article-title":"A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T\u00a0cell therapy","volume":"30","author":"Meeuwsen","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2022.11.007_bib27","doi-asserted-by":"crossref","first-page":"e004409","DOI":"10.1136\/jitc-2021-004409","article-title":"WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma","volume":"10","author":"van Amerongen","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omto.2022.11.007_bib28","doi-asserted-by":"crossref","first-page":"197ra103","DOI":"10.1126\/scitranslmed.3006034","article-title":"Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T\u00a0cells","volume":"5","author":"Cameron","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omto.2022.11.007_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/icb.2016.12","article-title":"Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors","volume":"94","author":"Szomolay","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.omto.2022.11.007_bib30","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omto.2022.11.007_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI97482","article-title":"Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia","volume":"129","author":"van der Lee","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omto.2022.11.007_bib32","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.4049\/jimmunol.165.11.6229","article-title":"Peptide-MHC class I tetrameric complexes display exquisite ligand specificity","volume":"165","author":"Burrows","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2022.11.007_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI86175","article-title":"Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T\u00a0cell response","volume":"127","author":"van Bergen","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omto.2022.11.007_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.14180","article-title":"Artisan PCR: rapid identification of full-length immunoglobulin rearrangements without primer binding bias","volume":"178","author":"Koning","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omto.2022.11.007_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nar\/gkg085","article-title":"IMGT, the international ImMunoGeneTics database","volume":"31","author":"Lefranc","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omto.2022.11.007_bib36","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a Hub for mass spectrometry-based proteomics evidences.","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1016\/j.omto.2023.100738","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000}}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T17:22:10Z","timestamp":1709313730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770522001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":36,"alternative-id":["S2372770522001425"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2022.11.007","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.omto.2023.100738","asserted-by":"object"}]},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A library of cancer testis specific T\u00a0cell receptors for T\u00a0cell receptor gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}